Anbio Biotechnology (NASDAQ:NNNN) Stock Price Down 13.2% – What’s Next?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price traded down 13.2% during trading on Thursday . The company traded as low as $11.00 and last traded at $10.0580. 39,557 shares changed hands during mid-day trading, a decline of 10% from the average session volume of 43,944 shares. The stock had previously closed at $11.59.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Anbio Biotechnology Price Performance

The company has a 50 day moving average price of $16.38.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.